Delivery Order SPE2DR25D6037-SPE2DR26FXL0E
Award Date 1/10/26
Potential Completion Date 1/12/26
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,891.40 delivery order to AmerisourceBergen Drug Corp for Atropine 0.4 mg/mL vials under a firm fixed price contract. This non-set-aside award was issued on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Atropine is a critical medication used in military and federal healthcare settings for emergency medical treatment,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,404.59 for Atropine 0.4 mg/mL vials on December 2, 2025, with completion scheduled for December 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Atropine is a critical pharmaceutical used in military and federal medical supply chains for emergency medical treatment,...
- The Defense Logistics Agency awarded a $4,976.44 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Atropine 0.4 mg/ml vials. This firm fixed-price contract, which is expected to be completed by August 21, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal procurement standards...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/mL vials under a firm fixed-price contract valued at $16,471.67. The contract was competitively awarded without set-aside provisions and requires completion by June 9, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $4,109.75 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL syringes (10 mL units). The contract, awarded on January 9, 2026, with an ultimate completion date of January 12, 2026, was competitively awarded with no set-aside designation and employs firm fixed-price pricing. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value...
- The Defense Logistics Agency awarded a delivery order valued at $1,269.70 to AmerisourceBergen Drug Corp for the supply of Atropine 0.4 mg/mL vials. This award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes a firm fixed-price delivery order contract type with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Atropine 0.4 mg/mL vials with a ceiling value of $3,339.71 on September 24, 2025. This firm fixed-price delivery order, with completion targeted for September 25, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The award was made on a non-set-aside basis through open competition, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $3,732.22 to AmerisourceBergen Drug Corp for the supply of Atropine 0.4 mg/mL vials. This non-competitive delivery order utilizes firm fixed pricing and was awarded on December 2, 2025, with an ultimate completion date of December 3, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,444.70 to AmerisourceBergen Drug Corp for the supply of Atropine Sulfate Injectable. The contract, issued on May 10, 2024, with an ultimate completion date of May 13, 2024, utilizes firm fixed-price pricing under a non-set-aside, competitively awarded delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,843.93 delivery order for Atropine 0.4 mg/mL vials, with completion scheduled for December 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier within the...